Cargando…
(655) Outcomes of Immunosuppression Reduction During Covid-19 Infection in Heart Transplant Patients
PURPOSE: Reduction in immunosuppression (IS) is universally recommended in the setting of infection, but its effect on outcomes in the setting of COVID-19 has not been established. The purpose of this study is to characterize the impact of IS reduction strategies on disease severity and outcomes of...
Autores principales: | Sauers, E., Clark, J., Kotton, C., Lewis, G., Doucette, M., Waldman, G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068100/ http://dx.doi.org/10.1016/j.healun.2023.02.669 |
Ejemplares similares
-
ODP655 Apathetic Hyperthyroidism
por: Seetharaman, Kavita
Publicado: (2022) -
CLINICAL CHARACTERISTICS, OUTCOMES AND IMMUNOSUPPRESSION STRATEGIES OF HEART TRANSPLANT RECIPIENTS INFECTED WITH COVID-19
por: Ilonze, Onyedika J., et al.
Publicado: (2021) -
Delayed Neutropenia in Heart Transplant Recipients Following COVID-19 Diagnosis
por: Doucette, M., et al.
Publicado: (2022) -
Impact of Infection-Related Immunosuppressant Reduction on Kidney Transplant Outcomes: A Retrospective Study Considering the Temporal Dynamics of Immunosuppressive Requirements
por: Yang, Bo, et al.
Publicado: (2023) -
Epidemiology and outcomes of 655 diabetic foot patients in a Brazilian university hospital
por: de Loiola Cisneros, Ligia, et al.
Publicado: (2015)